The Role of the Hospitalist: A Focus on Oncology Treatment Adverse Events



This activity is provided by Integrity Continuing Education, Inc.


This activity is supported by educational grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo, Inc.


Hospital admission is a frequent occurrence among patients with cancer, but their hospital stay often has features that may be different compared with patients without cancer. Management of these patients is complicated by drug-drug complications and serious grade treatment-related adverse events (trAEs) from their cancer treatment, which can be challenging. Hospitalists and other hospital-based clinicians need guidance and insight on the optimal monitoring, management, and intervention needed in these situations.


Bradley Christensen, MD
Texas Oncology
Baylor University Medical Center
Dallas, Texas

Release date: December 22, 2022
Expiration date: December 22, 2023
Estimated time to complete activity: 60 minutes

This educational activity has been designed to meet the needs of hospitalists, general internists, subspecialists, and family practitioners caring for hospitalized patients.


Upon completion of this educational activity, participants should be able to:

  • Identify the grade ≥3 trAEs associated with immune checkpoint inhibitors, antibody-drug conjugates, and cellular therapies
  • Devise an initial diagnostic and treatment plan for serious trAEs

There are no fees for participating and receiving CME credit for this activity. During the period of December 22, 2022 through December 22, 2023, participants must:

  • Read the learning objectives
  • Complete the pretest
  • Study the educational activity
  • Complete the posttest and the evaluation form

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 66% or better.

A link to the downloadable presentation slides will be provided once the program evaluation has been completed.




Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Integrity Continuing Education, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


For information about ACCME accreditation of this activity, please contact Integrity Continuing Education, Inc. at (855) 835-4004 or


Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any financial relationships with ineligible companies. All identified relevant financial relationships are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. All relevant financial relationships have been mitigated.

The following faculty/planners reported the financial relationships or relationships to products or devices they have with ineligible companies related to the content of these CME activities:

Bradley Christensen, MD does not have any financial relationships with any ineligible companies to report.

The Integrity Continuing Education, Inc. planners and managers have nothing to disclose.


This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


When you participate in an online educational activity sponsored by Integrity Continuing Education, Inc., you will be asked for your name, degree(s), affiliation(s), street address, telephone number and…(continued)


Minimum Processor: Intel Pentium 4, 2.33 + GHz (or equivalent)
Operating Systems: Windows XP, Windows 2000, Windows Vista, Windows 7, Windows 10, and Mac OS
Plug-in: Adobe® Flash® Player 10

  • Adobe® Flash® Player 10 plug-in should be downloaded
  • Click on the “Agree and install now” button after unchecking the optional McAfee Security Scan Plus

For optimal performance, the use of Internet Explorer below 8 is not recommended

For a full listing of recommended operating systems, browsers, and system configurations, please click on the link below:
Click here for more information on minimum system requirements


The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Continue to Pretest